- Home
- ATHE vs SBEV Comparison
ATHE vs SBEV Comparison
Compare ATHE & SBEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATHE
- SBEV
- Stock Information
- Founded
- ATHE 1997
- SBEV 1992
- Country
- ATHE Australia
- SBEV United States
- Employees
- ATHE N/A
- SBEV N/A
- Industry
- ATHE Biotechnology: Pharmaceutical Preparations
- SBEV Beverages (Production/Distribution)
- Sector
- ATHE Health Care
- SBEV Consumer Staples
- Exchange
- ATHE Nasdaq
- SBEV Nasdaq
- Market Cap
- ATHE 10.1M
- SBEV 10.9M
- IPO Year
- ATHE N/A
- SBEV N/A
- Fundamental
- Price
- ATHE $1.07
- SBEV $0.22
- Analyst Decision
- ATHE Buy
- SBEV Strong Buy
- Analyst Count
- ATHE 1
- SBEV 3
- Target Price
- ATHE $4.00
- SBEV $1.50
- AVG Volume (30 Days)
- ATHE 13.7K
- SBEV 548.1K
- Earning Date
- ATHE 12-03-2024
- SBEV 11-15-2024
- Dividend Yield
- ATHE N/A
- SBEV N/A
- EPS Growth
- ATHE N/A
- SBEV N/A
- EPS
- ATHE N/A
- SBEV N/A
- Revenue
- ATHE $2,681,669.00
- SBEV $6,257,725.00
- Revenue This Year
- ATHE N/A
- SBEV N/A
- Revenue Next Year
- ATHE N/A
- SBEV $182.15
- P/E Ratio
- ATHE N/A
- SBEV N/A
- Revenue Growth
- ATHE 2.63
- SBEV N/A
- 52 Week Low
- ATHE $1.00
- SBEV $0.14
- 52 Week High
- ATHE $5.41
- SBEV $0.73
- Technical
- Relative Strength Index (RSI)
- ATHE 37.45
- SBEV 52.89
- Support Level
- ATHE $1.05
- SBEV $0.18
- Resistance Level
- ATHE $1.13
- SBEV $0.23
- Average True Range (ATR)
- ATHE 0.07
- SBEV 0.03
- MACD
- ATHE -0.01
- SBEV 0.00
- Stochastic Oscillator
- ATHE 23.88
- SBEV 82.14
About ATHE Alterity Therapeutics Limited
Alterity Therapeutics Ltd is active in the healthcare domain. The company is engaged in research collaborations for the treatment of Parkinsonian movement disorders, Alzheimer's disease, Huntington disease, and other neurodegenerative disorders. The company's drug candidate-PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. It has a drug candidate for Parkinson's disease and other movement disorders (ATH434). The Group operated in one segment, being researching and developing Parkinsonian and other neurodegenerative disorders.
About SBEV Splash Beverage Group Inc. (NV)
Splash Beverage Group Inc is a portfolio company managing multiple brands across several growth segments within the consumer beverage industry. The company's two reportable operating segments are: (1) the manufacture and distribution of non-alcoholic and alcoholic beverages, and (2) the retail sale of beverages and groceries online. The company generates the majority of its revenue from the E-Commerce segment. Qplash is a wholly owned division of Splash. It is the company's first entry point into the e-commerce channel. For beverage-alcohol products, the company operate within what is referred to as a "Three Tier Distribution System" where manufacturers are not permitted to sell directly to retailers, but instead, contract for local and regional distribution with independent distributors.